QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
QQQ   423.83 (-0.47%)
AAPL   166.97 (-0.61%)
MSFT   405.43 (-1.56%)
META   501.94 (+1.57%)
GOOGL   156.24 (+0.50%)
AMZN   179.21 (-1.14%)
TSLA   150.93 (-2.91%)
NVDA   846.26 (+0.70%)
AMD   154.65 (+0.41%)
NIO   4.01 (+2.56%)
BABA   68.88 (+0.09%)
T   16.24 (+0.74%)
F   12.02 (-0.17%)
MU   112.74 (-3.09%)
GE   153.92 (-1.12%)
CGC   8.05 (+24.04%)
DIS   113.02 (+0.07%)
AMC   2.92 (-2.01%)
PFE   25.33 (-0.35%)
PYPL   62.18 (-1.71%)
XOM   118.25 (-0.32%)
OTCMKTS:AWKNF

Awakn Life Sciences (AWKNF) Stock Price, News & Analysis

$0.11
-0.02 (-15.59%)
(As of 04/17/2024 ET)
Today's Range
$0.11
$0.13
50-Day Range
$0.08
$0.16
52-Week Range
$0.04
$0.36
Volume
1,900 shs
Average Volume
20,449 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AWKNF stock logo

About Awakn Life Sciences Stock (OTCMKTS:AWKNF)

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

AWKNF Stock Price History

AWKNF Stock News Headlines

Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Joanna Goddard Loves a Smash and Grab
Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Awakn Life Sciences Corp AWKNF
AWKNF Awakn Life Sciences Corp.
See More Headlines
Receive AWKNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Awakn Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:AWKNF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. George Scorsis (Age 46)
    Co-founder & Chairman of the Board
  • Mr. Anthony Tennyson
    Co-founder, President, CEO & Director
  • Mr. Jonathan James Held C.A. (Age 38)
    CPA, CA, Interim CFO, Chief Business Officer & Secretary
    Comp: $109.58k
  • Prof. David John Nutt DM
    FMedSci, FRCP, FRCPsych, FSB, Ph.D., Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer

AWKNF Stock Analysis - Frequently Asked Questions

How have AWKNF shares performed in 2024?

Awakn Life Sciences' stock was trading at $0.1012 at the beginning of the year. Since then, AWKNF shares have increased by 7.0% and is now trading at $0.1083.
View the best growth stocks for 2024 here
.

Are investors shorting Awakn Life Sciences?

Awakn Life Sciences saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 1,000 shares, a decrease of 9.1% from the March 15th total of 1,100 shares. Based on an average daily volume of 15,900 shares, the days-to-cover ratio is currently 0.1 days.
View Awakn Life Sciences' Short Interest
.

How do I buy shares of Awakn Life Sciences?

Shares of AWKNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AWKNF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners